Bacterial melanin in rat models of Parkinson′s disease: a potential neuroprotective strategy

Bacterial melanin in rat models of Parkinson′s disease: a potential neuroprotective strategy

Bibliographic Details
Main Author:	Tigran Petrosyan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=2;spage=211;epage=212;aulast=Petrosyan

Similar Items

Bacterial melanin promotes recovery after sciatic nerve injury in rats
by: Olga V Gevorkyan, et al.
Published: (2015-01-01)

Detection of Ca2+-dependent acid phosphatase activity identifies neuronal integrity in damaged rat central nervous system after application of bacterial melanin
by: Tigran R Petrosyan, et al.
Published: (2016-01-01)

Neuroprotection and Neurotransplantation Strategies in Models of Parkinson’s Disease
by: Galpern, Wendy R.
Published: (1996)

Propolis as A Potential Disease-Modifying Strategy in Parkinson’s Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
by: Valeria C. Gonçalves, et al.
Published: (2020-05-01)

Parkinson’s disease-associated melanin steal
by: Hinz M, et al.
Published: (2014-12-01)

Parkinson’s Disease-Associated Melanin Steal [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
by: Edward C. Lauterbach, et al.
Published: (2012-01-01)

Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease
by: Alireza Sarkaki, et al.
Published: (2016-09-01)

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease
by: M.M. Ferro, et al.
Published: (2007-01-01)

Neuroprotective Effect of Genistein : Studies in Rat Models of Parkinson’s and Alzheimer’s Disease
by: Bagheri, Maryam
Published: (2012)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
by: In Su Kim, et al.
Published: (2012-08-01)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
by: Ojha S, et al.
Published: (2015-10-01)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
by: Marie-Therese Armentero, et al.
Published: (2011-09-01)

Neuroprotective effect of quercetin in a model of Parkinson’s disease in rat: A histochemical analysis
by: Mehdi Mehdizadeh, et al.
Published: (2009-01-01)

Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease
by: Harry V. Vinters, et al.
Published: (2010-11-01)

Neuroprotective effect of quercetin in a model of Parkinson’s disease in rat: A histochemical analysis
by: Mehdi Mehdizadeh, et al.
Published: (2009-01-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Neuroprotective Treatments in Parkinson’s Disease
by: Elif, et al.
Published: (2019-12-01)

Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
by: Atul Kabra, et al.
Published: (2020-10-01)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson’s Disease
by: Jason R. Richardson, et al.
Published: (2013-01-01)

Riboflavin Has Neuroprotective Potential: Focus on Parkinson’s Disease and Migraine
by: Eyad T. Marashly, et al.
Published: (2017-07-01)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
by: Vidar Gundersen
Published: (2021-02-01)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
by: Janusz W. Błaszczyk, et al.
Published: (2018-10-01)

Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
by: Napoleon Torres, et al.
Published: (2017-10-01)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
by: Sumit Sarkar, et al.
Published: (2016-06-01)

An evaluation of the potentially neuroprotective properties of cannabinoids in a cell culture model of Parkinson's disease
by: Zeissler, Marie-Louise
Published: (2013)

Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
by: Jiawen Yuan, et al.
Published: (2016-01-01)

The neuroprotective effects of exogenous mitochondria in rat model of Parkinson''s disease and sciatic nerve injury
by: Chi-Chung Kuo, et al.
Published: (2017)

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
by: Carolina Sportelli, et al.
Published: (2020-06-01)

Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
by: Jacqueline A. Bayliss, et al.
Published: (2013-02-01)

Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.
by: Rafael Gonzalo-Gobernado, et al.
Published: (2013-01-01)

Neuroprotective Effect of Aqueous Extract of Berberis vulgaris L. in a Model of Parkinson’s Disease in Rat
by: F Salar, et al.
Published: (2010-12-01)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
by: Xiaoyan Sheng, et al.
Published: (2021-02-01)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
by: Bridget Martinez, et al.
Published: (2018-01-01)

Neuroprotective effect of geniposide on Parkinson's disease model mice
by: Yi-mei CHEN, et al.
Published: (2015-06-01)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
by: François-Xavier Blaudin de Thé, et al.
Published: (2016-01-01)

Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
by: Emanuela Esposito, et al.
Published: (2012-01-01)

Validation of an In-Vitro Parkinson’s Disease Model for the Study of Neuroprotection
by: Esra Nur Yiğit, et al.
Published: (2018-12-01)

Neuroprotective Agents for Management of Parkinson’s disease
by: Leila Kouti, et al.
Published: (2015-10-01)